One of Atrogis patent application was granted in the US (US 9,784,726). The patent describes inventions useful for finding compounds for the treatment of diseases such as type 2 diabetes. This was the second time such a patent was granted.
Month: October 2017
5MSEK fund granted
Atrogi was awarded a 5 MSEK grant. This very prestigeful grant from the SWElifes accelerator program was received in fierce competition with other applicants. The grant will be used to help bring one of the compounds that Atrogis is developing for the treatment of type 2 diabetes to the clinic.
